Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled - MS arising during Tocilizumab therapy for rheumatoid arthritis.
Incidence of human herpesvirus 6 in clinical samples from Swedish patients with demyelinating diseases.
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
Pulsed corticosteroid treatment in MS patients stabilizes disease activity following natalizumab withdrawal prior to switching to fingolimod.
[One case of pediatric multiple sclerosis with convulsions as initial symptoms].
Prospects of Cinnamon in Multiple Sclerosis.
Basophils are dispensable for the recovery of gross locomotion after spinal cord hemisection injury.
Purinergic signalling in the urinary tract in health and disease.
Role of Sortilin in Models of Autoimmune Neuroinflammation.
Proteomics Urine Analysis of Pregnant Women Suffering from Multiple Sclerosis.
Alternatively activated microglia and macrophages in the central nervous system.
Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
Strength: A Relevant Link to Functional Performance in the Neurodegenerative Disease of Adrenomyeloneuropathy.
Anti-JC Virus Antibody Prevalence in Canadian MS Patients.
Potassium channel antagonists 4-aminopyridine and the T-butyl carbamate derivative of 4-aminopyridine improve hind limb function in chronically non-ambulatory dogs; a blinded, placebo-controlled trial.
Is it correct for a woman with multiple sclerosis to forgo medication because she may become pregnant?
Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression.
Retrospective Cohort Study of Gender Differential in Risk of Multiple Sclerosis in Kuwait.
Chronic inflammatory demyelinating polyradiculoneuropathy with cholesterol deposits in a dog.
Decision-making impairment in patients with multiple sclerosis: a case-control study.
Does the changing sex ratio of multiple sclerosis give opportunities for intervention?
A novel internet-based method of capturing outcomes in multiple sclerosis.
Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome.
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Comments.]
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management.
Pages
« first
‹ previous
…
662
663
664
665
666
667
668
669
670
…
next ›
last »